Development of a diagnostic system for detection of specific antibodies and antigens against Middle East respiratory syndrome coronavirus

Harnessing an RNA-mediated chaperone for the assembly of influenza hemagglutinin in an immunologically relevant conformation

(2018) Seung Won Yang et al.   FASEB JOURNAL

Characterization of novel monoclonal antibodies against the MERS-coronavirus spike protein and their application in species-independent antibody detection by competitive ELISA

(2018) Shuetsu Fukushi et al.   JOURNAL OF VIROLOGICAL METHODS

MERS-CoV: Understanding the Latest Human Coronavirus Threat

(2018) et al.   Viruses-Basel

Middle East respiratory syndrome coronavirus (MERS-CoV) outbreak in South Korea, 2015: epidemiology, characteristics and public health implications

(2017) K.H. Kim et al.   JOURNAL OF HOSPITAL INFECTION

The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection

(2017) Lan Jiaming et al.   VACCINE

MERS-CoV spike nanoparticles protect mice from MERS-CoV infection

(2017) Christopher M. Coleman et al.   VACCINE

Assays for laboratory confirmation of novel human coronavirus (hCoV-EMC) infections

(2017) V M Corman et al.   Eurosurveillance

MERS-CoV diagnosis: An update

(2016) Sameera Al Johani et al.   Journal of Infection and Public Health

Comparative and kinetic analysis of viral shedding and immunological responses in MERS patients representing a broad spectrum of disease severity

(2016) Chan-Ki Min et al.   Scientific Reports

A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates

(2015) Karuppiah Muthumani et al.   Science Translational Medicine

Evaluation of candidate vaccine approaches for MERS-CoV

(2015) Lingshu Wang et al.   Nature Communications

Seroepidemiology of Middle East respiratory syndrome (MERS) coronavirus in Saudi Arabia (1993) and Australia (2014) and characterisation of assay specificity

(2014) M G Hemida et al.   Eurosurveillance

Current advancements and potential strategies in the development of MERS-CoV vaccines

(2014) Naru Zhang et al.   Expert Review of Vaccines

Virological and serological analysis of a recent Middle East respiratory syndrome coronavirus infection case on a triple combination antiviral regimen

(2014) Nikolaos Spanakis et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Pathogenesis of Middle East respiratory syndrome coronavirus

(2014) Judith MA van den Brand et al.   JOURNAL OF PATHOLOGY

Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice

(2014) Christopher M. Coleman et al.   VACCINE

Serological assays for emerging coronaviruses: Challenges and pitfalls

(2014) Benjamin Meyer et al.   VIRUS RESEARCH

Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013

(2013) R Perera et al.   Eurosurveillance

Middle East Respiratory Syndrome coronavirus (MERS-CoV) serology in major livestock species in an affected region in Jordan, June to September 2013

(2013) C Reusken et al.   Eurosurveillance

Crystal Structure of the Receptor-Binding Domain from Newly Emerged Middle East Respiratory Syndrome Coronavirus

(2013) Y. Chen et al.   JOURNAL OF VIROLOGY

The Spike Protein of the Emerging Betacoronavirus EMC Uses a Novel Coronavirus Receptor for Entry, Can Be Activated by TMPRSS2, and Is Targeted by Neutralizing Antibodies

(2013) S. Gierer et al.   JOURNAL OF VIROLOGY

Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26

(2013) Guangwen Lu et al.   NATURE

Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia

(2012) Ali M. Zaki et al.   NEW ENGLAND JOURNAL OF MEDICINE

Protein Solubility and Folding Enhancement by Interaction with RNA

(2008) Seong Il Choi et al.   PLoS One